Archived Monthly Oncology Tumor Boards: Management of Thyroid Carcinomas |
1.00 |
10/02/2023 - 12:00am to 10/02/2024 - 12:00am |
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024 |
1.00 |
10/10/2023 - 12:00am to 10/10/2024 - 12:00am |
Archived Monthly Oncology Tumor Boards: Identification and Management of Immuno-Oncology Targeted Therapy-Related Adverse Events in Renal Cell... |
1.00 |
10/26/2023 - 12:00am to 10/26/2024 - 12:00am |
NCCN Guidelines® Insights - B-Cell Lymphomas, Version 6.2023 |
1.00 |
11/10/2023 - 12:00am to 11/10/2024 - 12:00am |
Recorded Presentations from the NCCN 2023 Annual Congress: Hematologic Malignancies™ |
|
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Revolutionizing Hematologic Cancer Treatment: The Promise of Bispecific T-Cell Engagers |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Navigating the Challenges: Effective Management of Toxicities in CAR T-Cell Therapies |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Adult Acute Lymphocytic Leukemia: Strategies for Selection of Consolidation Therapy |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Acute Myeloid Leukemia: Selecting Induction Therapy Based on Biological Disease Factors |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Case Studies in the Management of Leukemia |
0.75 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Navigating Change: Best Practices for Integrating WHO/ICC Classification Systems in the Management of Hematologic Malignancies |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Management of Newly Diagnosed Multiple Myeloma Based on Risk Stratification |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Incorporating Immunotherapeutic Strategies in the Management of Relapsed/Refractory Multiple Myeloma |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Tackling Inequities in Multiple Myeloma: Practical Steps for Improving Access and Quality of Care |
1.00 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |
Advances in the Management of Classical Hodgkin Lymphoma |
0.50 |
12/01/2023 - 12:00am to 12/01/2024 - 12:00am |